Results 121 to 130 of about 14,546 (260)

Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial [PDF]

, 1998
Manuela Merli, Francesco Salerno, Oliviero Riggio, Roberto de Franchis, F Fiaccadori, Patrizia Meddi, Massimo Primignani, Giovanni Pedretti, Alessandra Maggi, L. Capocaccia, A Lovaria, U Ugolotti, Filippo Maria Salvatori, Mario Bezzi, Plinio Rossi   +14 more
openalex   +1 more source

Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. [PDF]

, 1996
Luis Colombato, Laurent Spahr, J P Martinet, M Dufresne, M Lafortune, Daphna Fenyves, Gilles Pomier–Layrargues   +6 more
openalex   +1 more source

Parallel Transjugular Intrahepatic Portosystemic Shunt with Viatorr\u3csup\u3e®\u3c/sup\u3e Stents for Primary TIPS Insufficiency: Case Series and Review of Literature [PDF]

, 2019
BACKGROUND Transjugular intrahepatic portosystemic shunts (TIPS) can alleviate complications of portal hypertension such as ascites and variceal bleeding by decreasing the portosystemic gradient.
Krohmer, Steven, Nisiewicz, Michael, Raissi, Driss, Yu, Qian   +3 more
core   +1 more source

Role of transjugular intrahepatic portosystemic shunt in the liver transplant setting [PDF]

Liver transplantation is currently the only curative therapy for patients with liver cirrhosis. Not all patients in the natural course of the disease will undergo transplantation, but the majority of them will experience portal hypertension and its ...
Cusi, Giulia, Di Cola, Simone, Esposito, Samuele, Fonte, Stefano, Gazda, Jakub, Lapenna, Lucia, Mattana, Marco, Merli, Manuela   +7 more
core   +1 more source

Outcome of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Hepatic Hydrothorax: A Systematic Review and Meta-analysis

Indian Journal of Radiology and Imaging
Background Around 5% of patients with cirrhosis of the liver develop hepatic hydrothorax (HH). For patients with refractory HH (RHH), transjugular intrahepatic portosystemic shunt (TIPS) has been investigated in small studies.
Suprabhat Giri, Ranjan Kumar Patel, Taraprasad Tripathy, Mansi Chaudhary, Prajna Anirvan, Swati Chauhan, Mitali Madhumita Rath, Manas Kumar Panigrahi   +7 more
doaj   +1 more source

Duodenal Variceal Bleeding Treated with a Transjugular Intrahepatic Portosystemic Shunt [PDF]

, 1995
P Sort, I. Elizalde, I. Llach, Faust Feu, Juan Carlos García‐Pagán, Joan Manel Salmerón, Antoni Mas, J. Bosch, J.M. Bordas, J Rodés   +9 more
openalex   +1 more source

Transjugular intrahepatic portosystemic shunt for refractory ascites: Shunt diameter-optimizing risks and benefits [PDF]

, 1997
K Somberg
openalex   +1 more source

Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting [PDF]

, 2000
Naga Chalasani, W.Scott Clark, L G Martin, Jeffrie Kamean, Mehran Ali Khan, Nilesh H. Patel, Thomas Boyer   +6 more
openalex   +1 more source

UEG Week 2025 Moderated Posters

United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley   +1 more source

Transjugular Intrahepatic Portosystemic Shunt Reduction for Medically Refractory Hepatic Encephalopathy

Journal of Clinical Interventional Radiology ISVIR
Purpose Transjugular intrahepatic portosystemic shunt (TIPS) is an established intervention for symptomatic portal hypertension, with many patients experiencing hepatic encephalopathy (HE) as an undesirable side effect.
Brandon Toliver, Matthew Thornburg, Adam Schmitz, Paul Haste   +3 more
doaj   +1 more source